These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 25538167

  • 21. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ, Boey A, Park BJ, Brandt ME.
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
    Song Y, Liu X, Yang Z, Meng X, Xue R, Yu J, Al-Hatmi AMS, de Hoog GS, Li R.
    Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD, Heidrich D, Corrêa C, Scroferneker ML, Vettorato G, Fuentefria AM, Goldani LZ.
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients.
    Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE.
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
    [Abstract] [Full Text] [Related]

  • 30. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 31. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
    Mukherjee PK, Chandra J, Yu C, Sun Y, Pearlman E, Ghannoum MA.
    Invest Ophthalmol Vis Sci; 2012 Jul 03; 53(8):4450-7. PubMed ID: 22669723
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Overinduction of CYP51A Gene After Exposure to Azole Antifungals Provides a First Clue to Resistance Mechanism in Fusarium solani Species Complex.
    D'Agostino M, Lemmet T, Dufay C, Luc A, Frippiat JP, Machouart M, Debourgogne A.
    Microb Drug Resist; 2018 Jul 03; 24(6):768-773. PubMed ID: 29676953
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y, Pang GR, Zhao DQ, Gao CW, Zhou LT, Sun ST, Wang BL, Chen ZJ.
    Zhonghua Yan Ke Za Zhi; 2010 Jan 03; 46(1):38-42. PubMed ID: 20388321
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Current antifungal treatment of fusariosis.
    Al-Hatmi AMS, Bonifaz A, Ranque S, Sybren de Hoog G, Verweij PE, Meis JF.
    Int J Antimicrob Agents; 2018 Mar 03; 51(3):326-332. PubMed ID: 28705676
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.